Aarti Pharmalabs Ltd (AARTIPHARM)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 910.05
% Change: 3.41% (Prev Close: 880.00)

Volume: 2,35,539
% Change: 53.81% (Prev Volume: 1,53,132)

Delivery: 1,21,000
Delivery % : 51.37
% Change: 54.48% (Prev Delivery: 78,325)

Turnover: 2,121 Lacs
% Change: 55.97% (Prev Turnover: 1,360)

πŸ’Ή EOD Valuation

P/E Ratio: 30.95
P/B Ratio: 4.15
Market Cap: 8245 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AARTIPHARM
Market Cap: 7626 Rs. Cr.
Face Value: 5.00 Rs.

52 Week High: 971.50
52 Week Low: 550.25

All-Time High: 971.50 Rs.
All-Time Low: 234.80 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
1.13% | -3.30% | 18.97% | 29.48% | 0.00%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 43.72%

Change (3Y | 1Y): 0.00% | -0.57%

Pledged %: 0.01%

FII Holding

FII Holding: 7.34%

Change (3Y | 1Y): 0.00% | -0.02%

DII Holding

DII Holding: 7.80%

Change (3Y | 1Y): 0.00% | 0.27%

Public Holding: 41.12%

🏦 Financial Strength

Debt to Equity: 0.21
Debt: 413.11 Rs. Cr.

Book Value: 219.55 Rs.
Current Ratio: 2.01
Interest Coverage: 13.22
Free Cash Flow: -112.32 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: -0.20%

Sales Growth Qtr (YOY | QoQ):
-30.48% | -31.50%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | 20.80% | -0.20%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 18.29%

Profit Growth Qtr (YOY | QoQ):
-10.73% | -43.97%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | 30.62% | 18.29%

EPS Rs.

EPS (TTM): 29.40 Rs.

EPS Qtr (Last Year | Latest):
6.12 Rs. | 5.46 Rs.

EPS Annual (Last Annual | Annual March):
23.93 Rs. | 30.05 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
0.00% | 0.00%

Net Profit Rs. Cr.

Net Profit (TTM): 266.45 Rs. Cr.

Net Profit (Annual - March): 272.40 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
55.45| 88.34 | 49.50

EBITDA Rs. Cr.

EBITDA (Quarter): 95.04 Rs. Cr.
EBITDA (Previous Yr Ql): 98.67 Rs. Cr.

EBITDA (Annual - March): 474.49 Rs. Cr.
EBITDA (Previous Annual): 390.37 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
0.00% | 31.34%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 23.71%

OPM Qtr (Previous | Current):
25.83% | 24.20%

OPM Annual (5 Yrs | Last Yr | March):
0.00% | 20.84% | 21.96%

Return on Equity %

ROE: 14.54%

ROE (5 Yrs | 3 Yrs | Last Yr):
0.00% | 13.64% | 13.06%

Return on Capital Employed %

ROCE: 17.44%

ROCE (5 Yrs | 3 Yrs | Last Yr):
17.38% | 16.72% | 16.62%

Return on Assets %

ROA (TTM): 9.93%

ROA (5 Yrs | 3 Yrs | Last Yr):
0.00% | 9.31% | 8.97%

PEG Ratio: 0.93
Dividend Yield: 0.59%

PE 3 Yrs: 24.67
PE 5 Yrs: 24.67

Dividend Yield: 0.59%

πŸ‘₯ Company

Aarti Pharmalabs Ltd

AARTIPHARM

Promoter Holding: %